Mengli Yang

3.3k total citations
10 papers, 159 citations indexed

About

Mengli Yang is a scholar working on Infectious Diseases, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengli Yang has authored 10 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Immunology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengli Yang's work include SARS-CoV-2 and COVID-19 Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Bacteriophages and microbial interactions (2 papers). Mengli Yang is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Immunotherapy and Immune Responses (3 papers) and Bacteriophages and microbial interactions (2 papers). Mengli Yang collaborates with scholars based in China, United States and Hong Kong. Mengli Yang's co-authors include Haoping Liu, Xiaozhong Peng, Eric Pearlman, Xiaopeng Tang, Min Zhang, Jiekai Chen, Jingwen Xu, Ling Xu, Chengbo Long and Feng‐Liang Liu and has published in prestigious journals such as Nature Communications, Nano Letters and PLoS Pathogens.

In The Last Decade

Mengli Yang

8 papers receiving 158 citations

Peers

Mengli Yang
Elisha Segrist United States
Alexander M. Horspool United States
Wilhelm Furnon United Kingdom
Venice Du Pont United States
Joel Southgate United Kingdom
Miao Mei China
A Ruhan China
Kang An China
Mengli Yang
Citations per year, relative to Mengli Yang Mengli Yang (= 1×) peers Haruaki Nobori

Countries citing papers authored by Mengli Yang

Since Specialization
Citations

This map shows the geographic impact of Mengli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengli Yang more than expected).

Fields of papers citing papers by Mengli Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengli Yang. The network helps show where Mengli Yang may publish in the future.

Co-authorship network of co-authors of Mengli Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Mengli Yang. A scholar is included among the top collaborators of Mengli Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengli Yang. Mengli Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Chen, Yunxia, Ming Xu, Yanwei Cheng, et al.. (2024). Confirming gastric tube placement in neurocritical patients using the combined effects of end-tidal CO2 and pH testing: A prospective diagnostic study. Intensive and Critical Care Nursing. 88. 103922–103922.
3.
Solis, Norma V., Michaela Marshall, Qing Yao, et al.. (2024). Hyphal Als proteins act as CR3 ligands to promote immune responses against Candida albicans. Nature Communications. 15(1). 3926–3926. 6 indexed citations
4.
Yang, Mengli, Norma V. Solis, Michaela Marshall, et al.. (2022). Control of β-glucan exposure by the endo-1,3-glucanase Eng1 in Candida albicans modulates virulence. PLoS Pathogens. 18(1). e1010192–e1010192. 35 indexed citations
5.
Long, Qiong, Ying Yang, Mengli Yang, et al.. (2022). Recombinant VLPs empower RBM peptides showing no immunogenicity in native SARS-COV-2 protein to elicit a robust neutralizing antibody response. Nanomedicine Nanotechnology Biology and Medicine. 41. 102527–102527. 4 indexed citations
6.
Yang, Zhongqian, Liangqun Hua, Mengli Yang, et al.. (2022). Polymerized porin as a novel delivery platform for coronavirus vaccine. Journal of Nanobiotechnology. 20(1). 260–260. 4 indexed citations
7.
Yang, Zhongqian, Liangqun Hua, Mengli Yang, et al.. (2021). RBD-Modified Bacterial Vesicles Elicited Potential Protective Immunity against SARS-CoV-2. Nano Letters. 21(14). 5920–5930. 26 indexed citations
8.
Wang, Gan, Mengli Yang, Zilei Duan, et al.. (2020). Dalbavancin binds ACE2 to block its interaction with SARS-CoV-2 spike protein and is effective in inhibiting SARS-CoV-2 infection in animal models. Cell Research. 31(1). 17–24. 76 indexed citations
9.
Yang, Mengli, et al.. (2020). Linking Sfl1 Regulation of Hyphal Development to Stress Response Kinases in Candida albicans. mSphere. 5(1). 7 indexed citations
10.
Guo, Lei, Yuan He, Heng Li, et al.. (2018). Monitoring and evaluation of immune status of female Kunming mice maintained in different biosafety level laboratories. Biology Open. 7(12). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026